CompoAtlas

Ashwagandha poudre

Food supplement declared in France, decision dated 11 November 2025

Ashwagandha poudre (l'herbe vive) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition.

Brand
l'herbe vive
Food business operator placing the product on the market
Elodie BUTIN
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Poudre
Daily dose
5 grammes
Directions for use
3 à 5 grammes par jour (1 cuillère à 2 cuillères à café) mélangés à une infusion, un lait, du miel, du ghee, une compote, un yaourt, un porridge...le matin au lever, ou le soir.
Intended populations
Population générale
Not recommended for (according to the manufacturer)
Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Problèmes cardiaques, Problèmes de foie, Sous antidépresseurs, Sous traitement pour la thyroïde, Utilisation prolongée
Objectives stated by the manufacturer (these are not authorised claims)
Système nerveux

Declaration 344787, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Withania somnifera (L.) DunalRacinePoudre (de plantes séchées ou broyées)5 g

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé avant 12 ans, pendant la grossesse et l’allaitement, en cas de pathologie thyroïdienne, hépatique, cardiaque, d’hyperandrogénie, de dépression ou de traitement sédatif. Pas d’utilisation prolongée.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Withania somnifera (L.) Dunal
    Read the warning, when it applies and the studies cited

    ASHWAGANDHA - WITHANIA SOMNIFERA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 28 February 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : l'herbe vive

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.